Related Experiment Videos
Serum CA 125 levels in patients with non-malignant liver diseases without ascites
J Collazos1, J Genolla, M T Allende
1Servicio de Medicina Interna, Hospital de Galdácano, Vizcaya.
The Clinical Investigator
|March 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Seroprevalence for measles among healthcare workers in Madrid, Spain.
The Journal of hospital infection·2023
Factors associated with sepsis development in 606 Spanish adult patients with cellulitis.
BMC infectious diseases·2020
Factors predictive of relapse in adult bacterial osteomyelitis of long bones.
BMC infectious diseases·2018
Dedicated breast PET value to evaluate BI-RADS 4 breast lesions.
European journal of radiology·2018
Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2018
Reduced clinicopathological influence of hormone-dependence on breast carcinomas in women older than 70 years.
The International journal of biological markers·2017
Are heart rate responses reproducible in the tilt-table test?
The Clinical investigator·1994
Cyclosporine A enhances total cell calcium independent of Na-K-ATPase in vascular smooth muscle cells.
The Clinical investigator·1994
Volumes and Na+/H+ antiporter activity of lymphocytes in patients with congestive heart failure.
The Clinical investigator·1994
Comparison between ethanol sclerotherapy and emptying with injection of saline in treatment of thyroid cysts.
The Clinical investigator·1994
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026